ScholarIQanswers from OpenAlex

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes

PaperCitations, authors & open-access status

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes have?

ScholarIQcitation count

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes has 1,096 citations in the OpenAlex counts ScholarIQ stores.

When was Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes published?

ScholarIQyear

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes has 2005 year in the ScholarIQ index.

What is the open-access status of Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes?

ScholarIQoa status

Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes has bronze oa status in the ScholarIQ index.

What is the DOI of Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes?

ScholarIQdoi

The DOI for Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes is on the source record.

What is the PMID of Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes?

ScholarIQpmid

The PMID for Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes is on the source record.

What is the OpenAlex record for Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes?

ScholarIQopenalex

The OpenAlex for Insulin Needs after CD3-Antibody Therapy in New-Onset Type 1 Diabetes is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial